28 Nov 2024 | News
Technophage congratulates INFARMED, I.P. on the approval of phage therapy in Portugal, a groundbreaking achievement celebrated alongside the release of the “Guiding Standard on the Use of Compounded Medications for Phage Therapy in the Hospital Context – Magistral...
27 Nov 2024 | Events
This year, we combined our traditional annual team-building with a festive Christmas celebration, bringing together all our collaborators for a memorable day. The event kicked off with insightful talks from our directors, who shared a summary of 2024, highlighted key...
6 Nov 2024 | News
We are thrilled to announce that Technophage has once again been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação (Agency for Competitiveness and Innovation) with the prestigious ‘PME Líder’ distinction for 2024! Receiving this honor for another...
22 Jul 2024 | News
Technophage has been featured in the recent article “The 7 Biotech Companies in Portugal You Should Know About in 2024” by Labiotech! This recognition is a validation to our team’s hard work, dedication, and innovative spirit in advancing...
5 Jul 2024 | News
We are thrilled to announce that Technophage was selected by Innovate UK as one of the 19 most promising solutions globally in the fight against antibiotic resistance! Technophae’s CEO and CSO participated in the Inward AMR Innovation Mission UK 2024, that took...
